Evaluation of the Expression Profile of Irinotecan-Induced Diarrhea in Patients with Colorectal Cancer

Irinotecan (CPT-11) is widely used for the treatment of unresectable colorectal cancer in combination with fluoropyrimidines, such as 5-fluorouracil and S-1. Diarrhea is one of the adverse effects associated with CPT-11 and frequently reported by patients treated with CPT-11-containing regimens comb...

Descripción completa

Detalles Bibliográficos
Autores principales: Okunaka, Mashiro, Kano, Daisuke, Matsui, Reiko, Kawasaki, Toshikatsu, Uesawa, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073045/
https://www.ncbi.nlm.nih.gov/pubmed/33921605
http://dx.doi.org/10.3390/ph14040377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073045/
https://www.ncbi.nlm.nih.gov/pubmed/33921605
http://dx.doi.org/10.3390/ph14040377

Ejemplares similares